References
Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507–18.
Jeremiah N, Neven B, Gentili M, Callebaut I, Maschalidi S, Stolzenberg M-C, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 2014;124(12):5516–20.
Tang X, Xu H, Zhou C, Peng Y, Liu H, Liu J, et al. STING-associated vasculopathy with onset in infancy in three children with new clinical aspect and unsatisfactory therapeutic responses to tofacitinib. J Clin Immunol. 2020;40(1):114–22.
Cao Y, Jiang L-P. The challenge of diagnosing SAVI: case studies. Pediatr Allergy Immunol Pulmonol. 2019;32(4):167–72.
Clarke SLN, Robertson L, Rice GI, Seabra L, Hilliard TN, Crow YJ, et al. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Pediatr Rheumatol Online J. 2020;18(1):37.
Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, et al. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017;8:2176.
Omoyinmi E, Melo Gomes S, Nanthapisal S, Woo P, Standing A, Eleftheriou D, et al. Stimulator of interferon genes-associated vasculitis of infancy. Arthritis Rheumatol Hoboken NJ. 2015;67(3):808.
Shoman W, El Chazli Y, ElSawy I, Aróstegui JI. First Egyptian patient with STING-associated vasculopathy with onset in infancy. Scand J Rheumatol. 2019;48(4):338–9.
Seo J, Kang J-A, Suh DI, Park E-B, Lee C-R, Choi SA, et al. Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. J Allergy Clin Immunol. 2017;139(4):1396–1399.e12.
Volpi S, Insalaco A, Caorsi R, Santori E, Messia V, Sacco O, et al. Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome. J Clin Immunol. 2019;39(5):476–85.
Balci S, Ekinci RMK, de Jesus AA, Goldbach-Mansky R, Yilmaz M. Baricitinib experience on STING-associated vasculopathy with onset in infancy: a representative case from Turkey. Clin Immunol Orlando Fla. 2020;212:108273.
Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, et al. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041–52.
Acknowledgments
Thanks are due to Shalini N. Jhangiani, Zeynep H. Coban-Akdemir, and Haowei Du from the Baylor College of Medicine Human Genome Sequencing Center and Baylor-Hopkins Center for Mendelian Genomics for the whole exome sequencing and bioinformatics support and Anaid Reyes from the Texas Children’s Hospital Section of Immunology, Allergy, and Retrovirology for the administrative support.
Funding
This work was supported by National Institutes of Health (NIH-NHGRI/NHLBI UM1 HG006542) (to the Baylor-Hopkins Center for Mendelian Genomics).
Author information
Authors and Affiliations
Contributions
GA, AJ: Patient management, concept of the manuscript, critical review of manuscript for important intellectual content, and final approval of the version to be published
AP: Patient management, concept and draft of manuscript
AK, AR, MS: laboratory support
BY, IC: Genetic analysis by whole exome sequencing
SS: Patient management, important intellectual content, and final approval of the version to be published
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Supplementary Figure 1
Clinical photograph of index patient (P1) shows reduced mouth opening (A) and retrognathia (B) (JPG 147 kb)
Supplementary Figure 2
Sanger sequencing showing a heterozygous missense mutation in the exon 5 of STING1 gene (hg19; NM_198282) in the index patient (P1), brother of index patient (P2) and father of index patient (P3) (Chr5:138860432C>T: exon5:c.463G>A:p.V155M) (JPG 147 kb)
Supplementary Table 1
Summary of clinical and laboratory investigations in the index patient and family members (DOCX 23 kb)
Rights and permissions
About this article
Cite this article
Anjani, G., Jindal, A.K., Prithvi, A. et al. Deforming Polyarthritis in a North Indian Family—Clinical Expansion of STING-Associated Vasculopathy with Onset in Infancy (SAVI). J Clin Immunol 41, 209–211 (2021). https://doi.org/10.1007/s10875-020-00872-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-020-00872-w